During the second quarter, we sold out four stock positions and added two new ones to the portfolio. Read more here.
Tenax Therapeutics, Inc. downgraded to Hold ahead of Aug 2026 phase 3 TNX-103 data in PH-HFpEF; weigh 6MWD odds, downside, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results